Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chris Denning

Showing results (91-100 of 113) with videos related to

Pageof 12
Sort By:
Journal of Molecular and Cellular Cardiology|June 19, 2026
Structural, biophysical and cellular assessment of filamin C M82K: A test case for VUS interpretation in cardiomyopathyMaya Noureddine, Bethany A I Jones, Oseloka C M Oliobi, et al.
Stem Cell Reports|October 14, 2020
Comparison of 10 Control hPSC Lines for Drug Screening in an Engineered Heart Tissue FormatIngra Mannhardt, Umber Saleem, Diogo Mosqueira, et al.
Scientific Reports|July 26, 2023
Chronic activation of human cardiac fibroblasts in vitro attenuates the reversibility of the myofibroblast phenotypeCaitlin Hall, Jonathan P Law, Jasmeet S Reyat, et al.
Biochimica Et Biophysica Acta|November 3, 2015
Cardiomyocytes from human pluripotent stem cells: From laboratory curiosity to industrial biomedical platformChris Denning, Viola Borgdorff, James Crutchley, et al.
Reproductive Biomedicine Online|November 9, 2005
Human embryonic stem cells: towards therapies for cardiac disease. Derivation of a Dutch human embryonic stem cell lineAnja van de Stolpe, Stieneke van den Brink, Marga van Rooijen, et al.
European Heart Journal|May 10, 2018
CRISPR/Cas9 editing in human pluripotent stem cell-cardiomyocytes highlights arrhythmias, hypocontractility, and energy depletion as potential therapeutic targets for hypertrophic cardiomyopathyDiogo Mosqueira, Ingra Mannhardt, Jamie R Bhagwan, et al.
Journal of Medical Microbiology|March 18, 2021
Comparative effects of viral-transport-medium heat inactivation upon downstream SARS-CoV-2 detection in patient samplesJamie L Thompson, Angela Downie Ruiz Velasco, Alice Cardall, et al.
The Journal of Physiology|February 15, 2026
Human-derived cardiac-neural microtissues reveal catecholaminergic polymorphic ventricular tachycardia is also a disease of the sympathetic neuronNi Li, Chenchen Zhang, Mengying Xu, et al.
Methods and Protocols|March 22, 2022
Direct RT-qPCR Assay for the Detection of SARS-CoV-2 in Saliva SamplesFrancesco Saverio Tarantini, Siyu Wu, Harry Jenkins, et al.
Cardiovascular Research|May 27, 2026
A titin truncating variant linked to atrial fibrillation increases atrial profibrotic signalling and cholinergic sensitivityMax J Cumberland, Albert Dasí, Naeramit Sontayananon, et al.
Pageof 12

Showing results (91-100 of 113) with videos related to

Sort By:
Pageof 12
Journal of Molecular and Cellular Cardiology|June 19, 2026
Structural, biophysical and cellular assessment of filamin C M82K: A test case for VUS interpretation in cardiomyopathyMaya Noureddine, Bethany A I Jones, Oseloka C M Oliobi, et al.
Stem Cell Reports|October 14, 2020
Comparison of 10 Control hPSC Lines for Drug Screening in an Engineered Heart Tissue FormatIngra Mannhardt, Umber Saleem, Diogo Mosqueira, et al.
Scientific Reports|July 26, 2023
Chronic activation of human cardiac fibroblasts in vitro attenuates the reversibility of the myofibroblast phenotypeCaitlin Hall, Jonathan P Law, Jasmeet S Reyat, et al.
Biochimica Et Biophysica Acta|November 3, 2015
Cardiomyocytes from human pluripotent stem cells: From laboratory curiosity to industrial biomedical platformChris Denning, Viola Borgdorff, James Crutchley, et al.
Reproductive Biomedicine Online|November 9, 2005
Human embryonic stem cells: towards therapies for cardiac disease. Derivation of a Dutch human embryonic stem cell lineAnja van de Stolpe, Stieneke van den Brink, Marga van Rooijen, et al.
European Heart Journal|May 10, 2018
CRISPR/Cas9 editing in human pluripotent stem cell-cardiomyocytes highlights arrhythmias, hypocontractility, and energy depletion as potential therapeutic targets for hypertrophic cardiomyopathyDiogo Mosqueira, Ingra Mannhardt, Jamie R Bhagwan, et al.
Journal of Medical Microbiology|March 18, 2021
Comparative effects of viral-transport-medium heat inactivation upon downstream SARS-CoV-2 detection in patient samplesJamie L Thompson, Angela Downie Ruiz Velasco, Alice Cardall, et al.
The Journal of Physiology|February 15, 2026
Human-derived cardiac-neural microtissues reveal catecholaminergic polymorphic ventricular tachycardia is also a disease of the sympathetic neuronNi Li, Chenchen Zhang, Mengying Xu, et al.
Methods and Protocols|March 22, 2022
Direct RT-qPCR Assay for the Detection of SARS-CoV-2 in Saliva SamplesFrancesco Saverio Tarantini, Siyu Wu, Harry Jenkins, et al.
Cardiovascular Research|May 27, 2026
A titin truncating variant linked to atrial fibrillation increases atrial profibrotic signalling and cholinergic sensitivityMax J Cumberland, Albert Dasí, Naeramit Sontayananon, et al.
Pageof 12